Browsing byAuthorMahfoud, F
Showing results 1 to 7 of 7
| Issue Date | Title | Author(s) |
| 2019-01 | Association of medication adherence and depression with the control of low-density lipoprotein cholesterol and blood pressure in patients at high cardiovascular risk. | Katzmann, JL; Mahfoud, F; Böhm, M; Schulz, M; Laufs, U |
| 2020-10 | Development and implementation of blood pressure screening and referral guidelines for German community pharmacists. | Schulz, M; Griese-Mammen, N; Schumacher, PM; Strauch, D; Freudewald, L; Said, A; Tsuyuki, RT; Laufs, U; Kintscher, U; Böhm, M; Mahfoud, F |
| 2017-12-01 | Do patients with diabetes type 2 or chronic heart failure understand a medication plan? | Botermann, L; Wachter, A; Monzel, K; Krueger, K; Ewen, S; Mahfoud, F; Griese-Mammen, N; Schulz, M; Laufs, U |
| 2023-11-27 | Hidden sodium in effervescent-tablet dietary supplements and over-the-counter drugs: a comparative cross-sectional study. | Kunz, M; Götzinger, F; Jacobs, CM; Lauder, L; Ukena, C; Meyer, MR; Laufs, U; Schulz, M; Böhm, M; Mahfoud, F |
| 2021-10 | Impact of angiotensin receptor blocker product recalls on antihypertensive prescribing in Germany. | Rudolph, UM; Enners, S; Kieble, M; Mahfoud, F; Böhm, M; Laufs, U; Schulz, M |
| 2022 | Trends in Ezetimibe Prescriptions as Monotherapy or Fixed-Dose Combination in Germany 2012-2021. | Katzmann, JL; Kieble, M; Enners, S; Böhm, M; Mahfoud, F; Laufs, U; Schulz, M |
| 2022-02-27 | Use of fixed-dose combination antihypertensives in Germany between 2016 and 2020: an example of guideline inertia. | Mahfoud, F; Kieble, M; Enners, S; Kintscher, U; Laufs, U; Böhm, M; Schulz, M |
